Image de couverture de livre

Optimized FDA Pump

Fuente: Zenodo

Enregistré dans:

Détails bibliographiques
Auteur principal:	YILDIRIM, CANBERK
Format:	Recurso digital
Publié:	Zenodo 2025
Accès en ligne:	Acceder al recurso
Tags:	Ajouter un tag Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires

Pay Attention Later: Iterative Semantic Map Refinement for Low Resource Tasks
par: YILDIRIM, Alper
Publié: (2025)

Pay Attention Later: Iterative Semantic Map Refinement for Low Resource Tasks
par: YILDIRIM, Alper
Publié: (2025)

Pay Attention Later: Isolating the Semantic Alignment Tax via Iterative Semantic Map Refinement
par: YILDIRIM, Alper, et autres
Publié: (2025)

Pay Attention Later: The Semantic Alignment Tax Requires Decoupling Representation from Reasoning
par: YILDIRIM, Alper, et autres
Publié: (2025)

Pay Attention Later: The Semantic Alignment Tax Requires Decoupling Representation from Reasoning
par: YILDIRIM, Alper, et autres
Publié: (2025)

Pay Attention Later: Isolating the Semantic Alignment Tax via Iterative Semantic Map Refinement
par: YILDIRIM, Alper, et autres
Publié: (2025)

Synthesis and Biological Evaluation of Schiff Base Derivatives Exhibiting Antimicrobial, Antifungal, and Antibiofilm Activities Supported by Molecular Docking
par: Özgür YILMAZ, et autres
Publié: (2026)

Mechanical Optimization of Skateboard Pumping
par: Kogelbauer, Florian, et autres
Publié: (2023)

FDA AI Search: Making FDA-Authorized AI Devices Searchable
par: Kavishwar, Arun, et autres
Publié: (2025)

FDA Templates for EUA Submissions
par: RADx-rad
Publié: (2025)

FDA facing challenges: GAO
Publié: (2026)

A CW‐Pumped Dye Nanolaser With an Optimized Nanocavity
par: Yueyue Wei, et autres
Publié: (2024)

Participants in the FDA's Biomarker Qualification Program
par: Mahnum Shahzad, et autres
Publié: (2025)

Right to Trial & FDA Upgrade Act
par: Mike P. Sinn
Publié: (2026)

FDA lifts bans on fruit vapes
Publié: (2026)

Extended Bargmann FDA and non-relativistic gravity
par: Muñoz, Ariana, et autres
Publié: (2025)

AMA supports new FDA labeling on opioids
par: Alison Knopf
Publié: (2025)

FDA takes steps to restrict kratom byproduct
par: Alison Knopf
Publié: (2025)

Multipath Identification and Mitigation with FDA-MIMO Radar
par: Jia, Yizhen, et autres
Publié: (2024)

FDA regulatory considerations for oncology drug development
par: Hanlim Moon, et autres
Publié: (2024)

FDA approves capivasertib with fulvestrant for breast cancer
par: Mary Beth Nierengarten
Publié: (2024)

Additional Steps for Maintaining Public Trust in the FDA
par: Mitchell Berger
Publié: (2024)

Auf Pump
par: Ruoss, Matthias
Publié: (2025)

Performance Evaluation and Optimization of Air-to-Air Thermoelectric Heat Pump System
par: Bahk, Je-Hyeong, et autres
Publié: (2024)

Capacity Optimization of Micro‐Pumped Storage in Inter‐Station Energy Interconnection
par: Suliang Ma, et autres
Publié: (2026)

Pumping with Symmetry
par: Martínez, Julio Andrés Iglesias, et autres
Publié: (2023)

Pump head
Publié: (2003)

Pain at the Pump
par: Metschies, Gerhard
Publié: (2007)

Mechanistic Investigations of Photocatalytic Systems by Pump‐Pump‐Probe Spectroscopy
par: Daniel H. Cruz Neto, et autres
Publié: (2025)

Outcomes Following On-Pump Versus Of-Pump CABG: Apprising the “Bypassed”
par: Rohan Magoon
Publié: (2023)

FDA OKs lumateperone, accelerated deep TMS for MDD
par: Valerie A. Canady
Publié: (2025)

FDA changes buprenorphine labeling to favor higher doses
par: Alison Knopf
Publié: (2025)

From the FDA: Nicotine pouches can be dangerous to children
Publié: (2025)

Reorganizing the FDA is not a good idea: Former officials
Publié: (2025)

How Does the FDA Coordinate with International Regulators on AI?
par: Rasit Dinc
Publié: (2017)

Covertness in the Near Field: Maximizing the Covert Region with FDA
par: Lotfi, Fatemeh, et autres
Publié: (2024)

Coherent FDA Radar: Transmitter and Receiver Design and Analysis
par: Sun, Yan, et autres
Publié: (2024)

FDA Boosts the Progressive Supranuclear Palsy Rating Scale!
par: Cristina Sampaio
Publié: (2024)

FDA advisory committee rejects MDMA application for PTSD, but…
par: Alison Knopf
Publié: (2024)

FDA approves first immunotherapy drug for nasopharyngeal carcinoma
par: Mary Beth Nierengarten
Publié: (2024)